Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Molecular Scissoring Technology Market by Type (Cas9, TALENs and MegaTALs, ZFN, Others), by Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Others) and by End User (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering): Global Opportunity Analysis and Industry Forecast, 2023-2032

A11669

Pages: NA

Charts: NA

Tables: NA

Molecular scissoring technique involves the use of restriction enzymes commonly called molecular scissors. These enzymes cut the DNA near or at specific recognition sequences called restriction sites. One incision is made on each of the two strands of the DNA. The cleaved DNA can be transferred to vectors, which can then infect host cells. Vectors do this by hijacking the host cell machinery to reproduce. With this, molecular scissors find direct or indirect applications in molecular biology as tools for gene editing, mapping, and sequencing. Molecular scissoring technology further finds applications in the study of prevention and treatment of various diseases in plants, animals, and humans.

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the molecular scissoring technology market.

Top Impacting Factors

DNA mapping involves the use of molecular scissors to obtain structural information about the genetic material. In addition, mapping involves determining the order of the restriction enzyme site in the genome. Rise in number of studies done with the intent of DNA mapping in different countries is one of the factors that propel the growth of the molecular scissors market.

Many R&D activities are focused on the field of molecular cloning, restriction landmark genomic scanning, gene sequencing, and serial analysis of gene expression (SAGE), which could further propels the growth of the molecular scissors technology market.

In addition, molecular scissor helps in the production of personalized medicine, also known as precision medicine. It involves processes meant to help in the detection, prevention, and treatment of a disease in a patient using information from the patient's genetic makeup. Hence, this can act as a key growth factor of the growth.

However, with stringent policies, rules, and regulations that revolve around the use of molecular scissors, it is difficult to see the growth of the market at a high rate. In addition, molecular scissoring techniques are costly, which restrains the molecular scissoring technology market growth.

Key Market Trends

Recently, scientists in Israel have developed molecular scissoring software that helps cut DNA microscopically. This software takes readings from the existing machines and eliminates 99% of false cuts changes to improve efficacy while performing molecular scissoring.

There have been unique developments in CRISPR-Cas9. Cas9 can edit parts of the genome by altering and adding sections of the DNA. It is currently the most versatile and simplest method of genetic manipulation. In addition, Cas9 is the cheapest, fastest, and most reliable system for editing genes.

Drug developments such as that of PF-07321332 BY Pfizer, Inc. have been done following the principle behind molecular scissoring. This drug by Pfizer, Inc. was designed to act against the SARS-CoV-2 virus. The drug was designed to fit into the enzyme called protease, which cuts long protein chains. Proteases cut proteins into smaller pieces, which are then used as part of viral replication in the patient’s body. By fitting in proteases, the drug could block the scissoring action of the enzyme. If the drug is proven to be safe, it could be used widely.

Key Benefits of the Report

  • This study presents the analytical depiction of the molecular scissoring technology industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the molecular scissoring technology market share.
  • The current market is quantitatively analyzed to highlight the growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the molecular scissoring technology market .
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Molecular Scissoring Technology Market Report

  • Which are the leading players active in the molecular scissoring technology market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the molecular scissoring technology market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 in the industry?
  • What is molecular scissoring technology?
  • What is the molecular scissoring technology market prediction in the future?
  • What are the current trends and predicted trends?

Key Market Segments

  • By Type
    • Cas9
    • TALENs and MegaTALs
    • ZFN
    • Others
  • By Application
    • Cell Line Engineering
    • Animal Genetic Engineering
    • Plant Genetic Engineering
    • Others
  • By End User
    • Cell Line Engineering
    • Animal Genetic Engineering
    • Plant Genetic Engineering
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of LAMEA


Key Market Players

  • Recombinetics
  • Caribou Biosciences, Inc.
  • Cellectis
  • Thermo Fisher Scientific, Inc.
  • Editas Medicine
  • Precision BioSciences
  • Cibus, Inc.
  • Sangamo Therapeutics
  • Intellia Therapeutics, Inc.
  • Merck
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: MOLECULAR SCISSORING TECHNOLOGY MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Cas9

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. TALENs And MegaTALs

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. ZFN

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Others

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: MOLECULAR SCISSORING TECHNOLOGY MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Cell Line Engineering

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Animal Genetic Engineering

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Plant Genetic Engineering

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Others

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: MOLECULAR SCISSORING TECHNOLOGY MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Cell Line Engineering

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Animal Genetic Engineering

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Plant Genetic Engineering

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: MOLECULAR SCISSORING TECHNOLOGY MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Type

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Molecular Scissoring Technology Market

        • 7.2.6.1. Market Size and Forecast, By Type
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End User
      • 7.2.7. Canada Molecular Scissoring Technology Market

        • 7.2.7.1. Market Size and Forecast, By Type
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End User
      • 7.2.8. Mexico Molecular Scissoring Technology Market

        • 7.2.8.1. Market Size and Forecast, By Type
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End User
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Type

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Molecular Scissoring Technology Market

        • 7.3.6.1. Market Size and Forecast, By Type
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End User
      • 7.3.7. Germany Molecular Scissoring Technology Market

        • 7.3.7.1. Market Size and Forecast, By Type
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End User
      • 7.3.8. Italy Molecular Scissoring Technology Market

        • 7.3.8.1. Market Size and Forecast, By Type
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End User
      • 7.3.9. Spain Molecular Scissoring Technology Market

        • 7.3.9.1. Market Size and Forecast, By Type
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End User
      • 7.3.10. UK Molecular Scissoring Technology Market

        • 7.3.10.1. Market Size and Forecast, By Type
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End User
      • 7.3.11. Russia Molecular Scissoring Technology Market

        • 7.3.11.1. Market Size and Forecast, By Type
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End User
      • 7.3.12. Rest Of Europe Molecular Scissoring Technology Market

        • 7.3.12.1. Market Size and Forecast, By Type
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End User
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Type

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Molecular Scissoring Technology Market

        • 7.4.6.1. Market Size and Forecast, By Type
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End User
      • 7.4.7. Japan Molecular Scissoring Technology Market

        • 7.4.7.1. Market Size and Forecast, By Type
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End User
      • 7.4.8. India Molecular Scissoring Technology Market

        • 7.4.8.1. Market Size and Forecast, By Type
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End User
      • 7.4.9. South Korea Molecular Scissoring Technology Market

        • 7.4.9.1. Market Size and Forecast, By Type
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End User
      • 7.4.10. Australia Molecular Scissoring Technology Market

        • 7.4.10.1. Market Size and Forecast, By Type
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End User
      • 7.4.11. Thailand Molecular Scissoring Technology Market

        • 7.4.11.1. Market Size and Forecast, By Type
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End User
      • 7.4.12. Malaysia Molecular Scissoring Technology Market

        • 7.4.12.1. Market Size and Forecast, By Type
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End User
      • 7.4.13. Indonesia Molecular Scissoring Technology Market

        • 7.4.13.1. Market Size and Forecast, By Type
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End User
      • 7.4.14. Rest of Asia Pacific Molecular Scissoring Technology Market

        • 7.4.14.1. Market Size and Forecast, By Type
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End User
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Type

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Molecular Scissoring Technology Market

        • 7.5.6.1. Market Size and Forecast, By Type
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End User
      • 7.5.7. South Africa Molecular Scissoring Technology Market

        • 7.5.7.1. Market Size and Forecast, By Type
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End User
      • 7.5.8. Saudi Arabia Molecular Scissoring Technology Market

        • 7.5.8.1. Market Size and Forecast, By Type
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End User
      • 7.5.9. UAE Molecular Scissoring Technology Market

        • 7.5.9.1. Market Size and Forecast, By Type
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End User
      • 7.5.10. Argentina Molecular Scissoring Technology Market

        • 7.5.10.1. Market Size and Forecast, By Type
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End User
      • 7.5.11. Rest of LAMEA Molecular Scissoring Technology Market

        • 7.5.11.1. Market Size and Forecast, By Type
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End User
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Cibus, Inc.

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Intellia Therapeutics, Inc.

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Recombinetics

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Thermo Fisher Scientific, Inc.

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Precision BioSciences

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Merck

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Cellectis

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Editas Medicine

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Sangamo Therapeutics

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Caribou Biosciences, Inc.

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL MOLECULAR SCISSORING TECHNOLOGY MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL MOLECULAR SCISSORING TECHNOLOGY MARKET FOR CAS9, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL MOLECULAR SCISSORING TECHNOLOGY MARKET FOR TALENS AND MEGATALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL MOLECULAR SCISSORING TECHNOLOGY MARKET FOR ZFN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL MOLECULAR SCISSORING TECHNOLOGY MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL MOLECULAR SCISSORING TECHNOLOGY MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL MOLECULAR SCISSORING TECHNOLOGY MARKET FOR CELL LINE ENGINEERING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL MOLECULAR SCISSORING TECHNOLOGY MARKET FOR ANIMAL GENETIC ENGINEERING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL MOLECULAR SCISSORING TECHNOLOGY MARKET FOR PLANT GENETIC ENGINEERING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL MOLECULAR SCISSORING TECHNOLOGY MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL MOLECULAR SCISSORING TECHNOLOGY MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL MOLECULAR SCISSORING TECHNOLOGY MARKET FOR CELL LINE ENGINEERING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL MOLECULAR SCISSORING TECHNOLOGY MARKET FOR ANIMAL GENETIC ENGINEERING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL MOLECULAR SCISSORING TECHNOLOGY MARKET FOR PLANT GENETIC ENGINEERING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL MOLECULAR SCISSORING TECHNOLOGY MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA MOLECULAR SCISSORING TECHNOLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 20. U.S. MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 21. U.S. MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 22. U.S. MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 23. CANADA MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 24. CANADA MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 25. CANADA MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 28. MEXICO MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE MOLECULAR SCISSORING TECHNOLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 32. EUROPE MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 33. FRANCE MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 34. FRANCE MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 35. FRANCE MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 36. GERMANY MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 37. GERMANY MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 38. GERMANY MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 39. ITALY MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 40. ITALY MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 41. ITALY MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 42. SPAIN MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 43. SPAIN MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 44. SPAIN MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 45. UK MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 46. UK MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 47. UK MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 48. RUSSIA MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 49. RUSSIA MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 50. RUSSIA MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 51. REST OF EUROPE MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 52. REST OF EUROPE MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 53. REST OF EUROPE MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC MOLECULAR SCISSORING TECHNOLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 58. CHINA MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 59. CHINA MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 60. CHINA MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 61. JAPAN MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 62. JAPAN MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 63. JAPAN MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 64. INDIA MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 65. INDIA MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 66. INDIA MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH KOREA MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 70. AUSTRALIA MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 71. AUSTRALIA MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 72. AUSTRALIA MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 73. THAILAND MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 74. THAILAND MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 75. THAILAND MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 76. MALAYSIA MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 77. MALAYSIA MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 78. MALAYSIA MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 79. INDONESIA MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 80. INDONESIA MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 81. INDONESIA MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA MOLECULAR SCISSORING TECHNOLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 88. LAMEA MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 89. BRAZIL MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 90. BRAZIL MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 91. BRAZIL MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH AFRICA MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH AFRICA MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 94. SOUTH AFRICA MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 95. SAUDI ARABIA MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 96. SAUDI ARABIA MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 97. SAUDI ARABIA MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 98. UAE MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 99. UAE MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 100. UAE MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 101. ARGENTINA MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 102. ARGENTINA MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 103. ARGENTINA MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 104. REST OF LAMEA MOLECULAR SCISSORING TECHNOLOGY, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 105. REST OF LAMEA MOLECULAR SCISSORING TECHNOLOGY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 106. REST OF LAMEA MOLECULAR SCISSORING TECHNOLOGY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 107. CIBUS, INC.: KEY EXECUTIVES
  • TABLE 108. CIBUS, INC.: COMPANY SNAPSHOT
  • TABLE 109. CIBUS, INC.: OPERATING SEGMENTS
  • TABLE 110. CIBUS, INC.: PRODUCT PORTFOLIO
  • TABLE 111. CIBUS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. INTELLIA THERAPEUTICS, INC.: KEY EXECUTIVES
  • TABLE 113. INTELLIA THERAPEUTICS, INC.: COMPANY SNAPSHOT
  • TABLE 114. INTELLIA THERAPEUTICS, INC.: OPERATING SEGMENTS
  • TABLE 115. INTELLIA THERAPEUTICS, INC.: PRODUCT PORTFOLIO
  • TABLE 116. INTELLIA THERAPEUTICS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. RECOMBINETICS: KEY EXECUTIVES
  • TABLE 118. RECOMBINETICS: COMPANY SNAPSHOT
  • TABLE 119. RECOMBINETICS: OPERATING SEGMENTS
  • TABLE 120. RECOMBINETICS: PRODUCT PORTFOLIO
  • TABLE 121. RECOMBINETICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
  • TABLE 123. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • TABLE 124. THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
  • TABLE 125. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
  • TABLE 126. THERMO FISHER SCIENTIFIC, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. PRECISION BIOSCIENCES: KEY EXECUTIVES
  • TABLE 128. PRECISION BIOSCIENCES: COMPANY SNAPSHOT
  • TABLE 129. PRECISION BIOSCIENCES: OPERATING SEGMENTS
  • TABLE 130. PRECISION BIOSCIENCES: PRODUCT PORTFOLIO
  • TABLE 131. PRECISION BIOSCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. MERCK: KEY EXECUTIVES
  • TABLE 133. MERCK: COMPANY SNAPSHOT
  • TABLE 134. MERCK: OPERATING SEGMENTS
  • TABLE 135. MERCK: PRODUCT PORTFOLIO
  • TABLE 136. MERCK: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. CELLECTIS: KEY EXECUTIVES
  • TABLE 138. CELLECTIS: COMPANY SNAPSHOT
  • TABLE 139. CELLECTIS: OPERATING SEGMENTS
  • TABLE 140. CELLECTIS: PRODUCT PORTFOLIO
  • TABLE 141. CELLECTIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. EDITAS MEDICINE: KEY EXECUTIVES
  • TABLE 143. EDITAS MEDICINE: COMPANY SNAPSHOT
  • TABLE 144. EDITAS MEDICINE: OPERATING SEGMENTS
  • TABLE 145. EDITAS MEDICINE: PRODUCT PORTFOLIO
  • TABLE 146. EDITAS MEDICINE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. SANGAMO THERAPEUTICS: KEY EXECUTIVES
  • TABLE 148. SANGAMO THERAPEUTICS: COMPANY SNAPSHOT
  • TABLE 149. SANGAMO THERAPEUTICS: OPERATING SEGMENTS
  • TABLE 150. SANGAMO THERAPEUTICS: PRODUCT PORTFOLIO
  • TABLE 151. SANGAMO THERAPEUTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. CARIBOU BIOSCIENCES, INC.: KEY EXECUTIVES
  • TABLE 153. CARIBOU BIOSCIENCES, INC.: COMPANY SNAPSHOT
  • TABLE 154. CARIBOU BIOSCIENCES, INC.: OPERATING SEGMENTS
  • TABLE 155. CARIBOU BIOSCIENCES, INC.: PRODUCT PORTFOLIO
  • TABLE 156. CARIBOU BIOSCIENCES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL MOLECULAR SCISSORING TECHNOLOGY MARKET SEGMENTATION
  • FIGURE 2. GLOBAL MOLECULAR SCISSORING TECHNOLOGY MARKET
  • FIGURE 3. SEGMENTATION MOLECULAR SCISSORING TECHNOLOGY MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN MOLECULAR SCISSORING TECHNOLOGY MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMOLECULAR SCISSORING TECHNOLOGY MARKET
  • FIGURE 11. MOLECULAR SCISSORING TECHNOLOGY MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. MOLECULAR SCISSORING TECHNOLOGY MARKET FOR CAS9, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. MOLECULAR SCISSORING TECHNOLOGY MARKET FOR TALENS AND MEGATALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. MOLECULAR SCISSORING TECHNOLOGY MARKET FOR ZFN, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. MOLECULAR SCISSORING TECHNOLOGY MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. MOLECULAR SCISSORING TECHNOLOGY MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 17. MOLECULAR SCISSORING TECHNOLOGY MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. MOLECULAR SCISSORING TECHNOLOGY MARKET FOR ANIMAL GENETIC ENGINEERING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. MOLECULAR SCISSORING TECHNOLOGY MARKET FOR PLANT GENETIC ENGINEERING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. MOLECULAR SCISSORING TECHNOLOGY MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. MOLECULAR SCISSORING TECHNOLOGY MARKET SEGMENTATION, BY BY END USER
  • FIGURE 22. MOLECULAR SCISSORING TECHNOLOGY MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. MOLECULAR SCISSORING TECHNOLOGY MARKET FOR ANIMAL GENETIC ENGINEERING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. MOLECULAR SCISSORING TECHNOLOGY MARKET FOR PLANT GENETIC ENGINEERING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 29. COMPETITIVE DASHBOARD
  • FIGURE 30. COMPETITIVE HEATMAP: MOLECULAR SCISSORING TECHNOLOGY MARKET
  • FIGURE 31. TOP PLAYER POSITIONING, 2024
  • FIGURE 32. CIBUS, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. CIBUS, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. CIBUS, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. INTELLIA THERAPEUTICS, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. INTELLIA THERAPEUTICS, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. INTELLIA THERAPEUTICS, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. RECOMBINETICS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. RECOMBINETICS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. RECOMBINETICS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. THERMO FISHER SCIENTIFIC, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. PRECISION BIOSCIENCES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. PRECISION BIOSCIENCES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. PRECISION BIOSCIENCES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. MERCK: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. MERCK: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. MERCK: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. CELLECTIS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. CELLECTIS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. CELLECTIS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. EDITAS MEDICINE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. EDITAS MEDICINE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. EDITAS MEDICINE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. SANGAMO THERAPEUTICS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. SANGAMO THERAPEUTICS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. SANGAMO THERAPEUTICS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. CARIBOU BIOSCIENCES, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. CARIBOU BIOSCIENCES, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. CARIBOU BIOSCIENCES, INC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Molecular Scissoring Technology Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue